Chad V. Pecot
Impact in
- Cancer Research top 1%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Oncology top 5%
- Cancer Cells and Metastasis
Papers in
-
- Angiogenesis and VEGF in Cancer 6
- RNA modifications and cancer 5
- RNA Interference and Gene Delivery 5
- Epigenetics and DNA Methylation 5
-
- MicroRNA in disease regulation 13
- Cancer-related molecular mechanisms research 11
- Co-authors
- Anil K. Sood (19 shared papers)Gabriel Lopez‐Berestein (9 shared papers)George A. Calin (1 shared paper)Robert L. Coleman (2 shared papers)Rajesha Rupaimoole (8 shared papers)Joseph M. DeSimone (2 shared papers)J. Christopher Luft (2 shared papers)Jillian L. Perry (4 shared papers)
- Journals
- Nature Communications (4 papers)Cancer Research (3 papers)Gynecologic Oncology (3 papers)Oncogene (3 papers)Clinical Cancer Research (2 papers)
- Partner nations
- United StatesRussiaChina
In The Last Decade
Chad V. Pecot
56 papers receiving 2.9k citations
Chad V. Pecot's Hit Papers
Peers
Comparison fields: 5 of 110
- Cancer Research 1.1k
- Oncology 865
- Molecular Biology 1.8k
- Biomaterials 294
- Immunology 389
Countries citing papers authored by Chad V. Pecot
This map shows the geographic impact of Chad V. Pecot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chad V. Pecot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chad V. Pecot more than expected).
Fields of papers citing papers by Chad V. Pecot
This network shows the impact of papers produced by Chad V. Pecot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chad V. Pecot. The network helps show where Chad V. Pecot may publish in the future.
Co-authors
The 25 scholars most cited alongside Chad V. Pecot, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 59 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | RNA interference in the clinic: challenges and future directions Hit paper breakdown → | 2010 | 654 |
| 2 | 2013 | 314 | |
| 3 | 2017 | 217 | |
| 4 | 2014 | 185 | |
| 5 | 2011 | 160 | |
| 6 | 2013 | 156 | |
| 7 | 2019 | 108 | |
| 8 | 2015 | 102 | |
| 9 | 2016 | 78 | |
| 10 | 2022 | 75 | |
| 11 | 2014 | 73 | |
| 12 | 2019 | 68 | |
| 13 | 2019 | 67 | |
| 14 | 2019 | 59 | |
| 15 | 2021 | 54 | |
| 16 | 2022 | 51 | |
| 17 | 2020 | 50 | |
| 18 | 2020 | 49 | |
| 19 | 2015 | 48 | |
| 20 | 2012 | 45 |
About Chad V. Pecot
Chad V. Pecot is a scholar working on Molecular Biology, Cancer Research, Oncology, Pulmonary and Respiratory Medicine and Immunology and Allergy, having authored 59 papers that have together received 2.9k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (13 papers), Cancer-related molecular mechanisms research (11 papers), Lung Cancer Treatments and Mutations (8 papers), Cell Adhesion Molecules Research (7 papers), Angiogenesis and VEGF in Cancer (6 papers), RNA modifications and cancer (5 papers), RNA Interference and Gene Delivery (5 papers) and Epigenetics and DNA Methylation (5 papers). The work is most often cited by research in Cancer Research (1.1k citations), Oncology (865 citations), Molecular Biology (1.8k citations), Biomaterials (294 citations) and Immunology (389 citations). Chad V. Pecot has collaborated with scholars based in United States, Russia and China. Frequent co-authors include Anil K. Sood, Gabriel Lopez‐Berestein, George A. Calin, Robert L. Coleman, Rajesha Rupaimoole, Joseph M. DeSimone, J. Christopher Luft, Jillian L. Perry, Kevin Reuter and Cristian Rodriguez‐Aguayo. Their work appears in journals such as Nature Communications, Cancer Research, Gynecologic Oncology, Oncogene and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.